Article

Comparative Efficacy and Safety of Poly (ADP-Ribose) Polymerase Inhibitors in Cancer: Systematic Review and Network Meta-Analysis

2025-03-11

Abstract excerpt

<h4>Background</h4> The clinical background of cancer patients is complex, and the efficacy and safety of different poly (ADP-ribose) polymerase inhibitors (PARPis) vary greatly. Therefore, we conducted a systematic review and network meta-analysis to compare the efficacy and safety of the six PARPis and systematically evaluated the differences in PARPis in the relevant clinical contexts. <h4>Methods</h4> Database...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7ce75415-0ee2-5f28-9fca-96e30b1bfade
DOI: 10.1101/2025.03.11.25323491

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparative Efficacy and Safety of Poly (ADP-Ribose) Polymerase Inhibitors in Cancer: Systematic Review and Network Meta-AnalysisDOI 10.1101/2025.03.11.25323491Read

Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis.Semantic proximity Read

Efficacy and safety of PARP inhibitors in the treatment of BRCA-mutated breast cancer: An updated systematic review and meta-analysis of randomized controlled trialsSemantic proximity Read

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitorsSemantic proximity Read

Managing Adverse Effects Associated With Poly (ADP-ribose) Polymerase Inhibitors in Ovarian Cancer: A Synthesis of Clinical Trial and Real-World DataSemantic proximity Read

Efficacy and safety analysis of PARP inhibitors combined with drugs for primary and relapsed ovarian cancer: A meta-analysis of randomized controlled trialsSemantic proximity Read

Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer: A Systematic Review and Meta-analysis.Semantic proximity Read

PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?Semantic proximity Read

PARP inhibitors: a tsunami of indications in different malignancies.Semantic proximity Read

DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: a meta-analysis and systematic reviewSemantic proximity Read

The efficacy and safety of PARP inhibitors in mCRPC with HRR mutation in second-line treatment: a systematic review and bayesian network meta-analysis.Semantic proximity Read

The recent advance and prospect of poly(ADP‐ribose) polymerase inhibitors for the treatment of cancerSemantic proximity Read